+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Central Nervous System Therapeutic Market

  • PDF Icon

    Report

  • 200 Pages
  • May 2024
  • Region: Global
  • Erevna Healthcare
  • ID: 5968585
The global central nervous system therapeutic market accounted for USD 112.91 billion in 2023 and is expected to reach USD 215.19 billion by 2034 with a CAGR of 6.07% during the forecast period 2024-2034. The market will grow as a result of factors such as the rising prevalence of CNS disorders, increased attention being paid to mental health, innovative CNS therapies, an aging population, increased government funding and initiatives, and strategic alliances and collaborations.

Important factors include the increased incidence and prevalence of CNS conditions such as multiple sclerosis, depression, anxiety disorders, Parkinson's disease, Alzheimer's disease, and epilepsy. It is anticipated that the burden of these diseases will rise with aging populations and changing lifestyles, increasing the need for efficient therapies. For instance, in December 2023, Novartis AG received FDA approval for a new medication for migraines. This broadens their offering in the field of CNS pain management.

By disease, the neurodegenerative disease segment accounted for the highest revenue segment in the global central nervous system therapeutic market in 2023 owing to the increasing prevalence of conditions like Alzheimer's and Parkinson's, advancements in research leading to new treatment options, and the rising aging population worldwide. Additionally, greater awareness and early diagnosis contribute to the demand for neurodegenerative disease treatments. For instance, in January 2024, Johnson & Johnson and Biogen partnered to co-develop and market a novel medication for ALS (amyotrophic lateral sclerosis). They are working together to expedite development by pooling their resources and expertise. Additionally, the CNS cancer segment is predicted to grow at the fastest CAGR during the forecast period owing to the increasing incidence of CNS tumors, advancements in diagnostic techniques allowing for early detection, development of targeted therapies, and growing investment in oncology research and development.

By drug class, the antidepressants segment accounted for the highest revenue-grossing segment in the global central nervous system therapeutic market in 2023 and is predicted to grow at the fastest CAGR during the forecast period owing to the growing prevalence of depression and mood disorders globally, increased acceptance of mental health treatment, expanding awareness campaigns, and the introduction of novel antidepressant drugs with improved efficacy and fewer side effects. For instance, in December 2023, the Bristol Myers Squibb Company expanded its current partnership with RXi Pharmaceuticals to explore next-generation medicines for CNS illnesses, including schizophrenia.

By distribution channel, the retail pharmacies segment accounted for the highest revenue-grossing segment in the global central nervous system therapeutic market in 2023 owing to the growing accessibility and convenience of retail pharmacies, rising demand for over-the-counter and prescription CNS medications, expansion of retail pharmacy chains, and increasing self-medication trends. For instance, in February 2024 Teva Pharmaceutical Industries Ltd. introduced a generic version of a popular ADHD drug to the US market. This broadens their selection of generic CNS medications and makes more reasonably priced treatments available to patients. Additionally, the specialty clinics segment is predicted to grow at the fastest CAGR during the forecast period owing to the rising demand for specialized neurological and psychiatric care, increasing prevalence of complex CNS disorders requiring multidisciplinary approaches, advancements in treatment modalities offered by specialty clinics, and growing investments in healthcare infrastructure and technology.

North American region is anticipated to have the highest revenue share during the forecast period owing to the presence of well-established healthcare infrastructure, high adoption rates of advanced CNS therapeutics, robust research and development activities, increasing prevalence of CNS disorders, favorable reimbursement policies, and growing awareness about mental health issues. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the increasing healthcare expenditure, expanding access to healthcare services, rising prevalence of CNS disorders due to demographic shifts and lifestyle changes, growing investments in healthcare infrastructure, and rising awareness about mental health issues in the region. For instance, in December 2023, Otsuka Pharmaceutical Co., Ltd. was granted permission to market a novel antiepileptic medication within the European Union. This increases their market penetration for epilepsy treatments.

This extensive research report concentrates on the size and projections of the global and regional markets from 2023 to 2034.

Report Scope:

  • Base Year: 2023
  • Forecast Period: 2024-2034
  • Study Coverage
  • Market Forecast by Disease, Drug Class, and Distribution Channel
  • Market Forecast for 5 Regions and 17+ Countries
  • North America (U.S. and Canada)
  • Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
  • Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
  • Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
  • MEA (South Africa, GCC, Rest of MEA)
  • Exhaustive Company Profiles of the Top 10+ Major Market Players

Segmentation: Central Nervous System Therapeutic Market Report 2023 - 2034

Central Nervous System Therapeutic Market Analysis & Forecast by Disease 2023 - 2034 (Revenue USD Bn)

  • Neurovascular Diseases
  • CNS Trauma
  • Mental Health
  • Anxiety Disorders
  • Epilepsy
  • Mood Disorders
  • Psychotic Disorders
  • Others
  • Neurodegenerative Diseases
  • Alzheimer's Disease
  • Parkinson’s Disease
  • Multiple Sclerosis
  • Huntington's Disease
  • Amyotrophic Lateral Sclerosis
  • Others
  • Infectious Diseases
  • CNS Cancer
  • Others

Central Nervous System Therapeutic Market Analysis & Forecast by Drug Class 2023 - 2034 (Revenue USD Bn)

  • Analgesics
  • Antidepressants
  • Anesthetics
  • Anti-Parkinson Drugs
  • Anti-Epileptics
  • Other Drug Classes

Central Nervous System Therapeutic Market Analysis & Forecast by Distribution Channel 2023 - 2034 (Revenue USD Bn)

  • Retail Pharmacies
  • Hospitals
  • Specialty clinics

Central Nervous System Therapeutic Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM
  • Middle East & Africa
  • South Africa
  • GCC
  • Rest of MEA

Table of Contents

1. Research Methodology
1.1. Study Objectives
1.2. Study Scope
1.3. Research Assumptions
1.4. Research Framework
2. Introduction
2.1. Market Definition
2.2. Global Central Nervous System Therapeutic Market Overview
3. Executive Summary
4. Market Environment Analysis
4.1. Porter’s 5 Forces Analysis
4.2. PESTEL Analysis
4.3. SWOT Analysis
5. Market Dynamics
5.1. Drivers Analysis
5.2. Restraints Analysis
5.3. Opportunities Analysis
5.4. Threats Analysis
5.5. Trend Analysis
6. COVID-19 Impact Analysis
7. Central Nervous System Therapeutic Market: Disease Estimates & Trend Analysis
7.1. Disease Segment Opportunity Analysis
7.2. Neurovascular Diseases
7.2.1. Neurovascular Diseases Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.3. CNS Trauma
7.3.1. CNS Trauma Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.4. Mental Health
7.4.1. Mental Health Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.4.1.1. Anxiety Disorders
7.4.1.1.1. Anxiety Disorders Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.4.1.2. Epilepsy
7.4.1.2.1. Epilepsy Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.4.1.3. Mood Disorders
7.4.1.3.1. Mood Disorders Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.4.1.4. Psychotic Disorders
7.4.1.4.1. Psychotic Disorders Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.4.1.5. Others
7.4.1.5.1. Others Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.5. Neurodegenerative Diseases
7.5.1. Neurodegenerative Diseases Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.5.1.1. Alzheimer's Disease
7.5.1.1.1. Alzheimer's Disease Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.5.1.2. Parkinson’s Disease
7.5.1.2.1. Parkinson’s Disease Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.5.1.3. Multiple Sclerosis
7.5.1.3.1. Multiple Sclerosis Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.5.1.4. Huntington's Disease
7.5.1.4.1. Huntington's Disease Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.5.1.5. Amyotrophic Lateral Sclerosis
7.5.1.5.1. Amyotrophic Lateral Sclerosis Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.5.1.6. Others
7.5.1.6.1. Others Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.6. Infectious Diseases
7.6.1. Infectious Diseases Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.7. CNS Cancer
7.7.1. CNS Cancer Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.8. Others
7.8.1. Others Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8. Central Nervous System Therapeutic Market: Drug Class Estimates & Trend Analysis
8.1. Drug Class Segment Opportunity Analysis
8.2. Analgesics
8.2.1. Analgesics Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.3. Antidepressants
8.3.1. Antidepressants Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.4. Anesthetics
8.4.1. Anesthetics Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.5. Anti-Parkinson Drugs
8.5.1. Anti-Parkinson Drugs Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.6. Anti-Epileptics
8.6.1. Anti-Epileptics Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.7. Other Drug Classes
8.7.1. Other Drug Classes Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9. Central Nervous System Therapeutic Market: Distribution Channel Estimates & Trend Analysis
9.1. Distribution Channel Segment Opportunity Analysis
9.2. Retail Pharmacies
9.2.1. Retail Pharmacies Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.3. Hospitals
9.3.1. Hospitals Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.4. Specialty clinics
9.4.1. Specialty clinics Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
10. Regional Market Analysis
10.1. Regional Market Opportunity Analysis
11. North America Central Nervous System Therapeutic Market
11.1. North America Central Nervous System Therapeutic Market
11.1.1. North America Central Nervous System Therapeutic Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.1.2. North America Central Nervous System Therapeutic Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
11.1.3. North America Central Nervous System Therapeutic Market Size and Forecast, By Disease, 2023-2034 (Revenue USD Bn)
11.1.4. North America Central Nervous System Therapeutic Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
11.1.5. North America Central Nervous System Therapeutic Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
11.2. U.S. Global Central Nervous System Therapeutic Market
11.2.1. U.S. Central Nervous System Therapeutic Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.2.2. U.S. Central Nervous System Therapeutic Market Size and Forecast, By Disease, 2023-2034 (Revenue USD Bn)
11.2.3. U.S. Central Nervous System Therapeutic Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
11.2.4. U.S. Central Nervous System Therapeutic Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
11.3. Canada Global Central Nervous System Therapeutic Market
11.3.1. Canada Central Nervous System Therapeutic Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.3.2. Canada Central Nervous System Therapeutic Market Size and Forecast, By Disease, 2023-2034 (Revenue USD Bn)
11.3.3. Canada Central Nervous System Therapeutic Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
11.3.4. Canada Central Nervous System Therapeutic Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12. Europe Global Central Nervous System Therapeutic Market
12.1. Europe Global Central Nervous System Therapeutic Market
12.1.1. Europe Central Nervous System Therapeutic Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.1.2. Europe Central Nervous System Therapeutic Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
12.1.3. Europe Central Nervous System Therapeutic Market Size and Forecast, By Disease, 2023-2034 (Revenue USD Bn)
12.1.4. Europe Central Nervous System Therapeutic Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
12.1.5. Europe Central Nervous System Therapeutic Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12.2. Germany Global Central Nervous System Therapeutic Market
12.2.1. Germany Central Nervous System Therapeutic Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.2.2. Germany Central Nervous System Therapeutic Market Size and Forecast, By Disease, 2023-2034 (Revenue USD Bn)
12.2.3. Germany Central Nervous System Therapeutic Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
12.2.4. Germany Central Nervous System Therapeutic Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12.3. UK Global Central Nervous System Therapeutic Market
12.3.1. UK Central Nervous System Therapeutic Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.3.2. UK Central Nervous System Therapeutic Market Size and Forecast, By Disease, 2023-2034 (Revenue USD Bn)
12.3.3. UK Central Nervous System Therapeutic Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
12.3.4. UK Central Nervous System Therapeutic Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12.4. France Global Central Nervous System Therapeutic Market
12.4.1. France Central Nervous System Therapeutic Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.4.2. France Central Nervous System Therapeutic Market Size and Forecast, By Disease, 2023-2034 (Revenue USD Bn)
12.4.3. France Central Nervous System Therapeutic Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
12.4.4. France Central Nervous System Therapeutic Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12.5. Spain Global Central Nervous System Therapeutic Market
12.5.1. Spain Central Nervous System Therapeutic Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.5.2. Spain Central Nervous System Therapeutic Market Size and Forecast, By Disease, 2023-2034 (Revenue USD Bn)
12.5.3. Spain Central Nervous System Therapeutic Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
12.5.4. Spain Central Nervous System Therapeutic Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12.6. Italy Global Central Nervous System Therapeutic Market
12.6.1. Italy Central Nervous System Therapeutic Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.6.2. Italy Central Nervous System Therapeutic Market Size and Forecast, By Disease, 2023-2034 (Revenue USD Bn)
12.6.3. Italy Central Nervous System Therapeutic Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
12.6.4. Italy Central Nervous System Therapeutic Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12.7. Rest of Europe Global Central Nervous System Therapeutic Market
12.7.1. Rest of Europe Central Nervous System Therapeutic Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.7.2. Rest of Europe Central Nervous System Therapeutic Market Size and Forecast, By Disease, 2023-2034 (Revenue USD Bn)
12.7.3. Rest of Europe Central Nervous System Therapeutic Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
12.7.4. Rest of Europe Central Nervous System Therapeutic Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13. Asia Pacific Global Central Nervous System Therapeutic Market
13.1. Asia Pacific Global Central Nervous System Therapeutic Market
13.1.1. Asia Pacific Central Nervous System Therapeutic Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.1.2. Asia Pacific Central Nervous System Therapeutic Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
13.1.3. Asia Pacific Central Nervous System Therapeutic Market Size and Forecast, By Disease, 2023-2034 (Revenue USD Bn)
13.1.4. Asia Pacific Central Nervous System Therapeutic Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
13.1.5. Asia Pacific Central Nervous System Therapeutic Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.2. Japan Global Central Nervous System Therapeutic Market
13.2.1. Japan Central Nervous System Therapeutic Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.2.2. Japan Central Nervous System Therapeutic Market Size and Forecast, By Disease, 2023-2034 (Revenue USD Bn)
13.2.3. Japan Central Nervous System Therapeutic Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
13.2.4. Japan Central Nervous System Therapeutic Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.3. China Global Central Nervous System Therapeutic Market
13.3.1. China Central Nervous System Therapeutic Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.3.2. China Central Nervous System Therapeutic Market Size and Forecast, By Disease, 2023-2034 (Revenue USD Bn)
13.3.3. China Central Nervous System Therapeutic Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
13.3.4. China Central Nervous System Therapeutic Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.4. India Global Central Nervous System Therapeutic Market
13.4.1. India Central Nervous System Therapeutic Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.4.2. India Central Nervous System Therapeutic Market Size and Forecast, By Disease, 2023-2034 (Revenue USD Bn)
13.4.3. India Central Nervous System Therapeutic Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
13.4.4. India Central Nervous System Therapeutic Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.5. South Korea Global Central Nervous System Therapeutic Market
13.5.1. South Korea Central Nervous System Therapeutic Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.5.2. South Korea Central Nervous System Therapeutic Market Size and Forecast, By Disease, 2023-2034 (Revenue USD Bn)
13.5.3. South Korea Central Nervous System Therapeutic Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
13.5.4. South Korea Central Nervous System Therapeutic Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.6. Australia Global Central Nervous System Therapeutic Market
13.6.1. Australia Central Nervous System Therapeutic Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.6.2. Australia Central Nervous System Therapeutic Market Size and Forecast, By Disease, 2023-2034 (Revenue USD Bn)
13.6.3. Australia Central Nervous System Therapeutic Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
13.6.4. Australia Central Nervous System Therapeutic Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.7. Rest of Asia Pacific Global Central Nervous System Therapeutic Market
13.7.1. Rest of Asia Pacific Central Nervous System Therapeutic Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.7.2. Rest of Asia Pacific Central Nervous System Therapeutic Market Size and Forecast, By Disease, 2023-2034 (Revenue USD Bn)
13.7.3. Rest of Asia Pacific Central Nervous System Therapeutic Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
13.7.4. Rest of Asia Pacific Central Nervous System Therapeutic Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14. Latin America Global Central Nervous System Therapeutic Market
14.1. Latin America Global Central Nervous System Therapeutic Market
14.1.1. Latin America Central Nervous System Therapeutic Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.1.2. Latin America Central Nervous System Therapeutic Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
14.1.3. Latin America Central Nervous System Therapeutic Market Size and Forecast, By Disease, 2023-2034 (Revenue USD Bn)
14.1.4. Latin America Central Nervous System Therapeutic Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
14.1.5. Latin America Central Nervous System Therapeutic Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14.2. Brazil Global Central Nervous System Therapeutic Market
14.2.1. Brazil Central Nervous System Therapeutic Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.2.2. Brazil Central Nervous System Therapeutic Market Size and Forecast, By Disease, 2023-2034 (Revenue USD Bn)
14.2.3. Brazil Central Nervous System Therapeutic Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
14.2.4. Brazil Central Nervous System Therapeutic Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14.3. Mexico Global Central Nervous System Therapeutic Market
14.3.1. Mexico Central Nervous System Therapeutic Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.3.2. Mexico Central Nervous System Therapeutic Market Size and Forecast, By Disease, 2023-2034 (Revenue USD Bn)
14.3.3. Mexico Central Nervous System Therapeutic Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
14.3.4. Mexico Central Nervous System Therapeutic Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14.4. Argentina Global Central Nervous System Therapeutic Market
14.4.1. Argentina Central Nervous System Therapeutic Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.4.2. Argentina Central Nervous System Therapeutic Market Size and Forecast, By Disease, 2023-2034 (Revenue USD Bn)
14.4.3. Argentina Central Nervous System Therapeutic Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
14.4.4. Argentina Central Nervous System Therapeutic Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14.5. Rest of Latin America Global Central Nervous System Therapeutic Market
14.5.1. Rest of Latin America Central Nervous System Therapeutic Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.5.2. Rest of Latin America Central Nervous System Therapeutic Market Size and Forecast, By Disease, 2023-2034 (Revenue USD Bn)
14.5.3. Rest of Latin America Central Nervous System Therapeutic Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
14.5.4. Rest of Latin America Central Nervous System Therapeutic Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
15. MEA Global Central Nervous System Therapeutic Market
15.1. MEA Global Central Nervous System Therapeutic Market
15.1.1. MEA Central Nervous System Therapeutic Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.1.2. MEA Central Nervous System Therapeutic Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
15.1.3. MEA Central Nervous System Therapeutic Market Size and Forecast, By Disease, 2023-2034 (Revenue USD Bn)
15.1.4. MEA Central Nervous System Therapeutic Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
15.1.5. MEA Central Nervous System Therapeutic Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
15.2. GCC Global Central Nervous System Therapeutic Market
15.2.1. GCC Central Nervous System Therapeutic Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.2.2. GCC Central Nervous System Therapeutic Market Size and Forecast, By Disease, 2023-2034 (Revenue USD Bn)
15.2.3. GCC Central Nervous System Therapeutic Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
15.2.4. GCC Central Nervous System Therapeutic Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
15.3. South Africa Global Central Nervous System Therapeutic Market
15.3.1. South Africa Central Nervous System Therapeutic Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.3.2. South Africa Central Nervous System Therapeutic Market Size and Forecast, By Disease, 2023-2034 (Revenue USD Bn)
15.3.3. South Africa Central Nervous System Therapeutic Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
15.3.4. South Africa Central Nervous System Therapeutic Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
15.4. Rest of MEA Global Central Nervous System Therapeutic Market
15.4.1. Rest of MEA Central Nervous System Therapeutic Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.4.2. Rest of MEA Central Nervous System Therapeutic Market Size and Forecast, By Disease, 2023-2034 (Revenue USD Bn)
15.4.3. Rest of MEA Central Nervous System Therapeutic Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
15.4.4. Rest of MEA Central Nervous System Therapeutic Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
16. Competitor Analysis
16.1. Company Market Share Analysis, 2023
16.2. Major Recent Developments
17. Company Profiles
17.1. Pfizer Inc.
17.2. Johnson & Johnson
17.3. Novartis AG
17.4. Eli Lilly and Company
17.5. Merck & Co., Inc.
17.6. AbbVie Inc.
17.7. AstraZeneca PLC
17.8. Bristol Myers Squibb Company
17.9. GlaxoSmithKline PLC
17.10. Biogen Inc.
17.11. Teva Pharmaceutical Industries Ltd.
17.12. Otsuka Pharmaceutical Co., Ltd.
17.13. UCB S.A.
17.14. Eisai Co., Ltd.
17.15. Lundbeck A/S
18. Conclusion19. Recommendations

Companies Mentioned

  • Pfizer Inc.
  • Johnson & Johnson
  • Novartis AG
  • Eli Lilly and Company
  • Merck & Co. Inc.
  • AbbVie Inc.
  • AstraZeneca PLC
  • Bristol Myers Squibb Company
  • GlaxoSmithKline PLC
  • Biogen Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Otsuka Pharmaceutical Co. Ltd.
  • UCB S.A.
  • Eisai Co. Ltd.
  • Lundbeck A/S